Literature DB >> 23883207

JOURNAL CLUB: CT dose optimization for whole-body PET/CT examinations.

Elena Tonkopi1, Andrew A Ross, Anita MacDonald.   

Abstract

OBJECTIVE. The objective of this study was to optimize CT protocols for whole-body PET/CT by reducing radiation dose while minimizing effects on image quality. MATERIALS AND METHODS. Before protocol optimization, a survey of 140 consecutive patients was conducted to establish the baseline dose from a whole-body PET/CT examination. Another sample of 100 patients was surveyed to evaluate the reduction of radiation dose after implementation of the new protocol. Effective dose from the CT component of the examination was estimated using dose-length product (DLP) values from reports generated by the scanner and anatomy-specific conversion factors. Twenty-six patients who underwent studies before and after the optimization were included in an analysis of image quality. All 26 patients had maintained the same weight between the examinations and were scanned in the same position using a similar technique except for the changes made for CT dose optimization. The studies were randomized and blinded for an experienced PET and CT reader who graded the imaging quality of anatomic structures. RESULTS. CT protocol optimization resulted in a 32% reduction of the mean CT radiation dose: The mean effective dose was reduced from 8.1 to 5.5 mSv. The blinded analysis of image quality showed no clinically significant degradation of the lower-dose studies. The only structures visualized statistically better on the higher-dose CT scans were the carotid arteries and the region of the posterior triangle. CONCLUSION. The results of this study showed that optimization of CT acquisition can effectively reduce radiation dose in a whole-body PET/CT examination without significantly sacrificing image quality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23883207     DOI: 10.2214/AJR.12.10495

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

Review 1.  Impact of hybrid molecular imaging in retroperitoneal fibrosis: a systematic review.

Authors:  Isidora T Grozdic Milojevic; Bogomir Milojevic; Dragana P Sobic-Saranovic; Vera M Artiko
Journal:  Rheumatol Int       Date:  2017-08-24       Impact factor: 2.631

2.  In vivo evaluation of PEGylated ⁶⁴Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT.

Authors:  Anncatrine Luisa Petersen; Jonas Rosager Henriksen; Tina Binderup; Dennis Ringkjøbing Elema; Palle Hedengran Rasmussen; Anne Mette Hag; Andreas Kjær; Thomas Lars Andresen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-08       Impact factor: 9.236

3.  Preoperative staging of non-small cell lung cancer: prospective comparison of PET/MR and PET/CT.

Authors:  Sang Min Lee; Jin Mo Goo; Chang Min Park; Soon Ho Yoon; Jin Chul Paeng; Gi Jeong Cheon; Young Tae Kim; Young Sik Park
Journal:  Eur Radiol       Date:  2016-02-16       Impact factor: 5.315

4.  Hybrid Imaging in Head and Neck Sarcoidosis.

Authors:  Isidora Grozdic Milojevic; Marijana Tadic; Dragana Sobic-Saranovic; Jelena Saponjski; Vera M Artiko
Journal:  J Clin Med       Date:  2019-06-05       Impact factor: 4.241

5.  National Diagnostic Reference Level (DRL) for nuclear medicine computed tomography-positron emission tomography hybrid imaging studies for kuwait population: second phase dose audit-2019.

Authors:  Michael Masoomi; Iman Al-Shammeri; Latifah Al-Kandari; Hany Elrahman; Jehan Al-Shammeri
Journal:  BJR Open       Date:  2021-11-24

6.  Effective dose estimation for oncological and neurological PET/CT procedures.

Authors:  Josep M Martí-Climent; Elena Prieto; Verónica Morán; Lidia Sancho; Macarena Rodríguez-Fraile; Javier Arbizu; María J García-Velloso; José A Richter
Journal:  EJNMMI Res       Date:  2017-04-24       Impact factor: 3.138

7.  Assessment of Effective Dose Received in Various Computed Tomography Protocols and Factors Affecting It.

Authors:  Vikrant Kumar; Sachin Tayal; Abbas Ali; Arun Gandhi
Journal:  Indian J Nucl Med       Date:  2021-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.